k dao KDAO2011
5 years 11 months ago
New #ACR RA guidelines is cost conscious:
1. DMARD naive: Preferred MTX over LEF>HCQ/SSZ and preferred MTX over biologic/tsDMARD
2. DMARD naive low DAS: HCQ or SSZ preferred >MTX>LEF
3. T2T goal LDA/remission
@rheumnow (thread)
sheila RHEUMarampa
5 years 11 months ago
Hepatitis B infexn in RA? Below is the ACR 2020 draft treatment guidelines in this patient population: @RheumNow #ACR20 https://t.co/C3zw4TWOpg
Eric Dein ejdein1
5 years 11 months ago
Here is rationale for this recommendation away from triple therapy even though it has not shown to be inferior treatment, but works better/better adherence #ACR20 @Rheumnow. https://t.co/fQPOjLEjoA https://t.co/XrimgQW7oH
Meral K. El Ramahi, MD MeralElRamahiMD
5 years 11 months ago
Switching or adding a DMARD in pts w/ moderate-high dz RA activity & hx of previous serious infection w/in the past 12 mos as opposed to starting/increasing GCs is conditionally recommended per draft recs of new ACR RA treatment guidelines. #ACR20 @rheumnow @CCalabreseDO
Eric Dein ejdein1
5 years 11 months ago
Draft #ACR20 Rx Recs for RA: MTX is conditionally recommended with NORMAL LFTs and no advanced fibrosis. Role of HCQ for NALFD has been suggested at ACR, but not enough for mod-high disease activity @RheumNow. https://t.co/QFF3BK1NF0
Dr. Rachel Tate uptoTate
5 years 11 months ago
New #ACR20 draft guidelines for RA treatment @RheumNow https://t.co/j8jUdgM4dD
Who has more comorbidities? Dr. Janet Pope
Dr. Janet Pope reviews abstract #1466 presented at the 2020 ACR annual meeting. Who has more comorbidities: OA, Gout, RA or PsA?
Eric Dein ejdein1
5 years 11 months ago
Draft #ACR20 Rx Recs for RA: Treatment recommendations for Hepatitis B - highest risk is for RTX for reactivation! @RheumNow. https://t.co/2KX99yf8pD
Meral K. El Ramahi, MD MeralElRamahiMD
5 years 11 months ago
Conditional recommendation to add bDMARD or tsDMARD in RA pts on maximally tolerated dose of MTX over adding HCQ+SSZ (triple therapy) per draft recommendation of new ACR RA treatment guidelines. #ACR20 @RheumNow @ElaineHusniMD https://t.co/MW0fOAeK09
Mrinalini Dey DrMiniDey
5 years 11 months ago
Study on #telehealth in #rheumatology patients in the US finds those with #comorbidities and high disease activity are most likely to take up remote consults.
Abs#1962 #ACR20 @RheumNow
https://t.co/aHiuoY507p https://t.co/8ScM9pkTZE
sheila RHEUMarampa
5 years 11 months ago
#ACR20 RA treatment recommendations:
On administration of MTX 👇@Rheumnow https://t.co/XPXx8dq8gY
Eric Dein ejdein1
5 years 11 months ago
Draft #ACR20 Rx Recs for RA: discontinue MTX over biologic or tsDMARD in "patients that strongly want to discontinue", conditional recommendation supported by SEAM-RA Abst#939 @RheumNow https://t.co/U7cDhHIYzA
Pregnancy Outcomes in AxSpa: Dr. Robert Chao
Dr. Robert Chao reviews abstracts #1498, #1323 and #1324 presented at the 2020 ACR annual meeting.
Mavrilimumab in Giant Cell Arteritis: Dr. Richard Conway
Dr. Conway discusses late-breaking abstract #L06 presented Monday at the ACR 2020 annual meeting.
Febuxostat bad for the heart? Not so FAST: Dr. Jeffrey Curtis
Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.
